Palvella Therapeutics director plans $3.70M stock sale

Earlier sales by George Jenkins carried reported values of $1,871,435.40, $2,028,904.50 and $266,805.53.

Rhea-AI Filing Summary

Palvella Therapeutics, Inc. (PVLA) is the issuer for director George Jenkins’s proposed sale of 27,500 common shares through Piper Sandler & Co., with an approximate sale date of October 13, 2026. The reported aggregate market value is $3,695,450.00; 14,408,407 shares are listed as outstanding. Earlier sales listed for Jenkins were 12,371 shares on September 11, 13,352 on September 14, and 1,777 on September 15, 2026.

Key Figures

Proposed sale: 27,500 common shares Aggregate market value: $3,695,450.00 Shares outstanding: 14,408,407 shares +3 more

6 metrics

Proposed sale 27,500 common shares Approximate sale date October 13, 2026

Aggregate market value $3,695,450.00 Proposed sale

Shares outstanding 14,408,407 shares Reported in the securities information

Earlier shares sold 12,371 shares September 11, 2026; reported sale value $1,871,435.40

Earlier shares sold 13,352 shares September 14, 2026; reported sale value $2,028,904.50

Earlier shares sold 1,777 shares September 15, 2026; reported sale value $266,805.53

Key Terms

Rule 144, aggregate market value, attorney-in-fact, Private Investment

4 terms

Rule 144 regulatory

"definition of "person" in paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

aggregate market value financial

"Aggregate market value"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

attorney-in-fact regulatory

"as attorney-in-fact for George Jenkins"

An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

Private Investment financial

"Private Investment"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many PVLA shares does George Jenkins plan to sell?

George Jenkins is named for a proposed sale of 27,500 common shares. Piper Sandler & Co. is listed as the broker, and October 13, 2026 is the approximate sale date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/13/2026 - 05:00 PM EDT Accepted by SEC EDGAR 10/13/2026 - 04:59 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001271081
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PALVELLA THERAPEUTICS, INC.
SEC File Number	001-37471
Address of Issuer	353 W. LANCASTER AVENUE SUITE 200 WAYNE PENNSYLVANIA 19087
Phone	(484) 253-1461
Name of Person for Whose Account the Securities are To Be Sold	JENKINS GEORGE M
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Piper Sandler & Co 350 North 5th Street, Suite 1000 Minneapolis MN 55401	27500	3695450.00	14408407	10/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	03/06/2017	Private Investment	George Jenkins			27500	03/06/2017	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
George Jenkins 353 W Lancaster Ave Ste 200 Wayne PA 19087	Common Stock	09/11/2026	12371	1871435.40
George Jenkins 353 W Lancaster Ave Ste 200 Wayne PA 19087	Common Stock	09/14/2026	13352	2028904.50
George Jenkins 353 W Lancaster Ave Ste 200 Wayne PA 19087	Common Stock	09/15/2026	1777	266805.53

144: Remarks and Signature

Remarks
Date of Notice	10/13/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/12/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Will Britton, a duly authorized representative of Piper Sandler & Co Corporate & Venture Services FA, as attorney-in-fact for George Jenkins
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)